We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Analysis

Executive Summary

An HHS Inspector General report finds that manufacturer safeguards may be inadequate to prevent copay coupon use in Medicare Part D. The finding puts CMS in a tricky position – how to limit any chance that coupons inducing use of high-priced brands without cutting off vital support for needy beneficiaries.